Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Y-mAbs Therapeutics
Biotech
IGM, Y-mAbs, Passage Bio and more ring in 2025 with layoffs
IGM, Y-mAbs, Passage Bio and Shoreline Biosciences have each revealed plans to cut jobs as they rework their pipelines and business structures.
Fraiser Kansteiner
Jan 10, 2025 2:44pm
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
Google DeepMind vet to join GSK—Chutes & Ladders
Oct 20, 2023 9:30am
Y-Mabs drops 3rd of staff, cancer vaccine ambitions
Jan 5, 2023 8:40am
No surprises: FDA rejects Y-mAbs' rare pediatric cancer drug
Dec 2, 2022 5:43am
Y-mAbs' rare disease drug roundly rejected by FDA AdComm
Oct 31, 2022 6:40am
